Qualigen Therapeutics, Inc. (QLGN) Financials
Stock symbol QLGN is outdated, potentially delisted? Maybe it is available on other exchange?
QLGN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2023 | 4.3 million | 6.0 million |
| June 30, 2023 | 13.1 million | 9.8 million |
| March 31, 2023 | 19.1 million | 10.3 million |
| Dec. 31, 2022 | 19.1 million | 10.3 million |
QLGN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2023 | 1.2 million | 122696 |
| June 30, 2023 | -3.0 million | 653919 |
| March 31, 2023 | -2.5 million | 1.4 million |
| Dec. 31, 2022 | -2.5 million | 1.4 million |
QLGN Net Income
No data available :(
QLGN Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2023 | 2.1 million | - | - |
| June 30, 2023 | 1.3 million | - | 1.4 million |
| March 31, 2023 | 7.0 million | - | 1.5 million |
| Dec. 31, 2022 | - | - | 1.7 million |
QLGN Shares Outstanding
QLGN Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2023 | 246418 | 1.4 million | 1.3 million | - |
| June 30, 2023 | 48409 | 1.3 million | 2.7 million | 169223 |
| March 31, 2023 | 244374 | 1.8 million | 2.7 million | 267129 |
| Dec. 31, 2022 | 244374 | 1.8 million | 2.9 million | - |
QLGN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2023 | - | - |
| June 30, 2023 | 1.6 million | 1.0 million |
| March 31, 2023 | 1.4 million | 1.1 million |
| Dec. 31, 2022 | 1.4 million | 1.1 million |
QLGN
Price: $3.04
52 week price:
Earnings Per Share: 6.30 USD
P/E Ratio: 0.45
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 69100
Market Capitalization: 4.8 million